attach research report excerpt
research report written
entir broker partner auerbach
grayson auerbach grayson
auerbach grayson distributing/provid
research report consider
maintain buy rate lift price target resm
result in-lin forecast highlight strong mask sale saa
revenu growth decis combin saa busi brightre
healthcarefirst matrixcar fulli interoper ecosystem creat
immedi leverag market share opportun saa portfolio uniqu
reach across us healthcar set relev chronic diseas extend
new diseas area resm custom care short term
earn upgrad invest thesi interplay saa
medic devic busi mutual benefici healthcar oper
continu discov incent prefer medic devic share real-tim therapi
data enterpris softwar system optim cost deliv care
snapshot report revenu growth non-gaap ep
ahead forecast theme includ impress
revenu growth especi tough comp strong mask growth solid
focu integr saa platform expand tech offer diseas
model chang oper earn estim reflect improv margin
outlook per guidanc sg synergi saa come one year ahead
wilson view sleep busi continu benefit connect care
strategi share gain evid flow gener mask categori
combin major saa busi brightre healthcarefirst matrixcar
yield cost effici expans address custom base market
share gain long sale runway ahead saa uniqu scope across medic
devic supplier home health long-term post-acut healthcar set
ultim strategi support market share gain core medic devic
busi ventil portabl oxygen concentr potenti upsid
saa revenu forecast driven us medicar chang necessit
enterpris softwar implement skill nurs sector patient driven
payment model implement octob
buy margin expans continu unfold
maintain buy rate lift price target
resm result in-lin forecast highlight strong
mask sale saa revenu growth decis combin
saa busi brightre healthcarefirst matrixcar
fulli interoper ecosystem creat immedi leverag market
share opportun saa portfolio uniqu reach across us
healthcar set relev chronic diseas extend
new diseas area resm custom care short term
earn upgrad invest thesi interplay
saa medic devic busi mutual benefici
healthcar oper continu discov incent prefer
medic devic share real-tim therapi data enterpris
softwar system optim cost deliv care
snapshot report revenu growth non-gaap
ep ahead forecast theme includ
impress revenu growth especi tough comp strong
mask growth solid saa growth guidanc suggest addit
effici go forward focu integr saa platform expand
tech offer diseas modal
model chang oper earn estim reflect improv
margin outlook per guidanc sg synergi saa come one year
ahead previou model
major saa busi
wilson view sleep busi continu benefit connect
care strategi share gain evid flow gener mask
healthcarefirst matrixcar yield cost effici expans
address custom base market share gain long sale runway
ahead saa uniqu scope across medic devic supplier home
health long-term post-acut healthcar set ultim
strategi support market share gain core medic devic
busi ventil portabl oxygen concentr potenti upsid
saa revenu forecast driven us medicar chang
necessit enterpris softwar implement skill nurs sector
patient driven payment model implement octob
valuat price target per cdi impli cash ep
ev/ebitda lift valuat primarili attribut longer term
benefit gross margin improv oper leverag increment
medic devic sale sleep respiratori
risk catalyst report
risk catalyst
risk advers reimburs cut sleep apnoea fund product
launch competitor litig includ patent infring suit
develop indic outsid sleep apnoea
share issu
analyst share compani n/a
issu wilson advisori stockbrok limit wilson abn australian financi servic licenc particip asx group
read conjunct disclosur disclaim report import disclosur regard compani subject report
explan recommend found end document
health equip suppli
profit loss
fund equiti
fund debt
fund cash
health equip suppli
tabl resm result vs wilson forecast pcp
strong revenu growth driven strong mask saa revenu growth
impress notabl mask sale us increas vs pcp
rest world vs pcp constant currenc term continu take
market share rel matur product cycl saa organ revenu growth high
singl digit matrixcar grow low doubl digit brightre grow
gross oper margin improv gross margin improv
compar pcp sg percentag revenu
improv vs pcp reflect effici associ integr
saa platform realiz meaning ahead expect
saa portfolio continu expand brightre soon offer addit featur hme
home medic equip provid relev chronic diseas space plan
product offer diabet incontin enter care propel compani
combin medic devic saa solut asthma copd space
partner lead pharmaci chain walgreen pilot program promis
outlook technolog abil captur copd patient candid
treatment plan long-term use devic across care continuum
ab varamerica flow mask flow mask net gross expenses- amortis tax rate net non-gaap net net juli
health equip suppli
solid expenditur guidanc manag provid follow guidanc
 expenditur revenu in-lin expect
sg expenditur start higher end rang improv
second half beat expect forecast reflect similar sg
synergi aris slowli
gross margin in-lin
tax rate in-lin
provid summari key chang forecast
tabl chang wilson forecast
health equip suppli
resm inc develop manufactur sell posit air pressur pap devic treatment sleep disord breath recent
year compani diversifi pap offer market oral applianc ventil form respiratori support
maintain buy rate lift price target resm result in-lin forecast highlight strong
mask sale saa revenu growth decis combin saa busi brightre healthcarefirst matrixcar
fulli interoper ecosystem creat immedi leverag market share opportun saa portfolio uniqu reach across us
healthcar set relev chronic diseas extend new diseas area resm custom care short term
earn upgrad invest thesi interplay saa medic devic busi mutual benefici
healthcar oper continu discov incent prefer medic devic share real-tim therapi data enterpris softwar
system optim cost deliv care
grow easier access diagnosi sleep disord
rel short product cycl refresh price point
new devic area
gross margin expos fx aud sgd vs usd
 sg typic net sale
product mix higher-end apap ventil bilevel mask
higher gross margin
competit intensifi low-end cpap market
net debt averag next month impli net
leverag
restor sustain industri us devic volum flow
increment margin benefit mix shift apap
risk view
increas competit price point
slower-than-expect market growth particularli challeng
price reimburs challeng usa elsewher
relat poor complianc cpap
health equip suppli
disclaim disclosur
